CRISPR Therapeutics
CRSP
#1717
Rank
$8.87 B
Marketcap
๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Country
$116.43
Share price
-3.98%
Change (1 day)
38.46%
Change (1 year)

Earnings for CRISPR Therapeutics (CRSP)

Earnings in 2021 (TTM): -$0.4 B

According to CRISPR Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.4 B. In 2020 the company made an earning of -$0.36 B a decrease over its 2019 earnings that were of $0.04 B. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for CRISPR Therapeutics from 2016 to 2021

Year Earnings Change
2021 (TTM)-$0.4 B11.56%
2020-$0.36 B-858.31%
2019$0.04 B-128.43%
2018-$0.17 B154.34%
2017-$0.07 B340.74%
2016-$0.02 B